Review



beas 2b cell  (ATCC)


Bioz Verified Symbol ATCC is a verified supplier
Bioz Manufacturer Symbol ATCC manufactures this product  
  • Logo
  • About
  • News
  • Press Release
  • Team
  • Advisors
  • Partners
  • Contact
  • Bioz Stars
  • Bioz vStars
  • 99

    Structured Review

    ATCC beas 2b cell
    Beas 2b Cell, supplied by ATCC, used in various techniques. Bioz Stars score: 99/100, based on 4012 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/product/crl+3588/BEAS-2B/pm42320433-336-0-7
    Average 99 stars, based on 4012 article reviews
    beas 2b cell - by Bioz Stars, 2026-09
    99/100 stars

    Images

    Related Articles

    other:

    Article Title: Multi-omics profiling reveals microenvironmental remodeling as a key driver of house dust mite-induced lung cancer progression
    Article Snippet: Human: BEAS-2B cells , ATCC , Cat# CRL-3588, RRID:CVCL_0168.



    Similar Products

    99
    ATCC beas 2b cell
    Beas 2b Cell, supplied by ATCC, used in various techniques. Bioz Stars score: 99/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/product/crl+3588/BEAS-2B/pm42320433-336-0-7
    Average 99 stars, based on 1 article reviews
    beas 2b cell - by Bioz Stars, 2026-09
    99/100 stars
      Buy from Supplier

    99
    ATCC human lung epithelial cells beas 2b
    Human Lung Epithelial Cells Beas 2b, supplied by ATCC, used in various techniques. Bioz Stars score: 99/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/product/crl+3588/BEAS-2B/pm42285371-56-0-17
    Average 99 stars, based on 1 article reviews
    human lung epithelial cells beas 2b - by Bioz Stars, 2026-09
    99/100 stars
      Buy from Supplier

    99
    ATCC beas 2b non cancerous bronchial cells
    Beas 2b Non Cancerous Bronchial Cells, supplied by ATCC, used in various techniques. Bioz Stars score: 99/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/product/crl+3588/BEAS-2B/pm42261900-100-0-4
    Average 99 stars, based on 1 article reviews
    beas 2b non cancerous bronchial cells - by Bioz Stars, 2026-09
    99/100 stars
      Buy from Supplier

    99
    ATCC human bronchial epithelial cell line beas 2b
    Human Bronchial Epithelial Cell Line Beas 2b, supplied by ATCC, used in various techniques. Bioz Stars score: 99/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/product/crl+3588/BEAS-2B/pm42260571-70-20-29
    Average 99 stars, based on 1 article reviews
    human bronchial epithelial cell line beas 2b - by Bioz Stars, 2026-09
    99/100 stars
      Buy from Supplier

    99
    ATCC epithelial cells beas 2b
    Epithelial Cells Beas 2b, supplied by ATCC, used in various techniques. Bioz Stars score: 99/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/product/crl+3588/BEAS-2B/pm42259463-71-21-27
    Average 99 stars, based on 1 article reviews
    epithelial cells beas 2b - by Bioz Stars, 2026-09
    99/100 stars
      Buy from Supplier

    99
    ATCC human bronchial epithelial cells
    Human Bronchial Epithelial Cells, supplied by ATCC, used in various techniques. Bioz Stars score: 99/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/product/crl+3588/BEAS-2B/pmc13275446-95-0-8
    Average 99 stars, based on 1 article reviews
    human bronchial epithelial cells - by Bioz Stars, 2026-09
    99/100 stars
      Buy from Supplier

    99
    ATCC beas 2b normal human bronchial epithelial cells
    Experimental validation of HLA-DPA1 and HLA-DPB1 downregulation. <t>(A)</t> <t>BEAS-2B</t> human bronchial epithelial cells were treated with IL-13 (20 ng/mL) for 24 h to establish an in vitro asthma cell model. Quantitative real-time PCR analysis showed that the mRNA expression levels of HLA-DPA1, HLA-DPB1 and CIITA were significantly decreased in the IL-13-treated group compared with the control group. (B) BEAS-2B human bronchial epithelial cells were treated with IL-13 (20 ng/mL) for 24 h to establish an in vitro asthma cell model. Western blot analysis showed that the protein expression levels of HLA-DPA1, HLA-DPB1 and CIITA were significantly decreased in the IL-13-treated group compared with the control group. (C) PBMCs were collected from children with asthma and healthy controls. Quantitative qPCR analysis revealed that the mRNA expression levels of HLA-DPA1 and HLA-DPB1 were significantly lower in PBMCs from the asthma group compared with the healthy control group. (D) Western blot analysis was performed to assess the protein expression levels of HLA-DPA1 and HLA-DPB1 in PBMCs. The results demonstrated that the protein levels of both genes were markedly downregulated in the asthma group compared with the healthy control group. GAPDH was used as a loading control. *P<0.05; **P<0.01; ***P<0.001; ****P<0.0001, Student’s t-test, one-way ANOVA, post hoc comparisons, Tukey’s test.
    Beas 2b Normal Human Bronchial Epithelial Cells, supplied by ATCC, used in various techniques. Bioz Stars score: 99/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/product/crl+3588/BEAS-2B/pmc13272086-98-0-9
    Average 99 stars, based on 1 article reviews
    beas 2b normal human bronchial epithelial cells - by Bioz Stars, 2026-09
    99/100 stars
      Buy from Supplier

    99
    ATCC normal human bronchial epithelial cell lines
    Experimental validation of HLA-DPA1 and HLA-DPB1 downregulation. <t>(A)</t> <t>BEAS-2B</t> human bronchial epithelial cells were treated with IL-13 (20 ng/mL) for 24 h to establish an in vitro asthma cell model. Quantitative real-time PCR analysis showed that the mRNA expression levels of HLA-DPA1, HLA-DPB1 and CIITA were significantly decreased in the IL-13-treated group compared with the control group. (B) BEAS-2B human bronchial epithelial cells were treated with IL-13 (20 ng/mL) for 24 h to establish an in vitro asthma cell model. Western blot analysis showed that the protein expression levels of HLA-DPA1, HLA-DPB1 and CIITA were significantly decreased in the IL-13-treated group compared with the control group. (C) PBMCs were collected from children with asthma and healthy controls. Quantitative qPCR analysis revealed that the mRNA expression levels of HLA-DPA1 and HLA-DPB1 were significantly lower in PBMCs from the asthma group compared with the healthy control group. (D) Western blot analysis was performed to assess the protein expression levels of HLA-DPA1 and HLA-DPB1 in PBMCs. The results demonstrated that the protein levels of both genes were markedly downregulated in the asthma group compared with the healthy control group. GAPDH was used as a loading control. *P<0.05; **P<0.01; ***P<0.001; ****P<0.0001, Student’s t-test, one-way ANOVA, post hoc comparisons, Tukey’s test.
    Normal Human Bronchial Epithelial Cell Lines, supplied by ATCC, used in various techniques. Bioz Stars score: 99/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/product/crl+3588/BEAS-2B/pm42253258-47-13-23
    Average 99 stars, based on 1 article reviews
    normal human bronchial epithelial cell lines - by Bioz Stars, 2026-09
    99/100 stars
      Buy from Supplier

    99
    ATCC beas 2b cells
    Experimental validation of HLA-DPA1 and HLA-DPB1 downregulation. <t>(A)</t> <t>BEAS-2B</t> human bronchial epithelial cells were treated with IL-13 (20 ng/mL) for 24 h to establish an in vitro asthma cell model. Quantitative real-time PCR analysis showed that the mRNA expression levels of HLA-DPA1, HLA-DPB1 and CIITA were significantly decreased in the IL-13-treated group compared with the control group. (B) BEAS-2B human bronchial epithelial cells were treated with IL-13 (20 ng/mL) for 24 h to establish an in vitro asthma cell model. Western blot analysis showed that the protein expression levels of HLA-DPA1, HLA-DPB1 and CIITA were significantly decreased in the IL-13-treated group compared with the control group. (C) PBMCs were collected from children with asthma and healthy controls. Quantitative qPCR analysis revealed that the mRNA expression levels of HLA-DPA1 and HLA-DPB1 were significantly lower in PBMCs from the asthma group compared with the healthy control group. (D) Western blot analysis was performed to assess the protein expression levels of HLA-DPA1 and HLA-DPB1 in PBMCs. The results demonstrated that the protein levels of both genes were markedly downregulated in the asthma group compared with the healthy control group. GAPDH was used as a loading control. *P<0.05; **P<0.01; ***P<0.001; ****P<0.0001, Student’s t-test, one-way ANOVA, post hoc comparisons, Tukey’s test.
    Beas 2b Cells, supplied by ATCC, used in various techniques. Bioz Stars score: 99/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/product/crl+3588/BEAS-2B/pmc13188120-81-0-2
    Average 99 stars, based on 1 article reviews
    beas 2b cells - by Bioz Stars, 2026-09
    99/100 stars
      Buy from Supplier

    99
    ATCC non small cell lung cancer nsclc cell lines h460
    Experimental validation of HLA-DPA1 and HLA-DPB1 downregulation. <t>(A)</t> <t>BEAS-2B</t> human bronchial epithelial cells were treated with IL-13 (20 ng/mL) for 24 h to establish an in vitro asthma cell model. Quantitative real-time PCR analysis showed that the mRNA expression levels of HLA-DPA1, HLA-DPB1 and CIITA were significantly decreased in the IL-13-treated group compared with the control group. (B) BEAS-2B human bronchial epithelial cells were treated with IL-13 (20 ng/mL) for 24 h to establish an in vitro asthma cell model. Western blot analysis showed that the protein expression levels of HLA-DPA1, HLA-DPB1 and CIITA were significantly decreased in the IL-13-treated group compared with the control group. (C) PBMCs were collected from children with asthma and healthy controls. Quantitative qPCR analysis revealed that the mRNA expression levels of HLA-DPA1 and HLA-DPB1 were significantly lower in PBMCs from the asthma group compared with the healthy control group. (D) Western blot analysis was performed to assess the protein expression levels of HLA-DPA1 and HLA-DPB1 in PBMCs. The results demonstrated that the protein levels of both genes were markedly downregulated in the asthma group compared with the healthy control group. GAPDH was used as a loading control. *P<0.05; **P<0.01; ***P<0.001; ****P<0.0001, Student’s t-test, one-way ANOVA, post hoc comparisons, Tukey’s test.
    Non Small Cell Lung Cancer Nsclc Cell Lines H460, supplied by ATCC, used in various techniques. Bioz Stars score: 99/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/product/crl+3588/BEAS-2B/pm41500341-56-8-22
    Average 99 stars, based on 1 article reviews
    non small cell lung cancer nsclc cell lines h460 - by Bioz Stars, 2026-09
    99/100 stars
      Buy from Supplier

    Image Search Results


    Experimental validation of HLA-DPA1 and HLA-DPB1 downregulation. (A) BEAS-2B human bronchial epithelial cells were treated with IL-13 (20 ng/mL) for 24 h to establish an in vitro asthma cell model. Quantitative real-time PCR analysis showed that the mRNA expression levels of HLA-DPA1, HLA-DPB1 and CIITA were significantly decreased in the IL-13-treated group compared with the control group. (B) BEAS-2B human bronchial epithelial cells were treated with IL-13 (20 ng/mL) for 24 h to establish an in vitro asthma cell model. Western blot analysis showed that the protein expression levels of HLA-DPA1, HLA-DPB1 and CIITA were significantly decreased in the IL-13-treated group compared with the control group. (C) PBMCs were collected from children with asthma and healthy controls. Quantitative qPCR analysis revealed that the mRNA expression levels of HLA-DPA1 and HLA-DPB1 were significantly lower in PBMCs from the asthma group compared with the healthy control group. (D) Western blot analysis was performed to assess the protein expression levels of HLA-DPA1 and HLA-DPB1 in PBMCs. The results demonstrated that the protein levels of both genes were markedly downregulated in the asthma group compared with the healthy control group. GAPDH was used as a loading control. *P<0.05; **P<0.01; ***P<0.001; ****P<0.0001, Student’s t-test, one-way ANOVA, post hoc comparisons, Tukey’s test.

    Journal: Frontiers in Immunology

    Article Title: Integrative multi-omics reveals that downregulation of HLA-DPA1/DPB1 drives macrophage immune-metabolic dysregulation in pediatric asthma

    doi: 10.3389/fimmu.2026.1835475

    Figure Lengend Snippet: Experimental validation of HLA-DPA1 and HLA-DPB1 downregulation. (A) BEAS-2B human bronchial epithelial cells were treated with IL-13 (20 ng/mL) for 24 h to establish an in vitro asthma cell model. Quantitative real-time PCR analysis showed that the mRNA expression levels of HLA-DPA1, HLA-DPB1 and CIITA were significantly decreased in the IL-13-treated group compared with the control group. (B) BEAS-2B human bronchial epithelial cells were treated with IL-13 (20 ng/mL) for 24 h to establish an in vitro asthma cell model. Western blot analysis showed that the protein expression levels of HLA-DPA1, HLA-DPB1 and CIITA were significantly decreased in the IL-13-treated group compared with the control group. (C) PBMCs were collected from children with asthma and healthy controls. Quantitative qPCR analysis revealed that the mRNA expression levels of HLA-DPA1 and HLA-DPB1 were significantly lower in PBMCs from the asthma group compared with the healthy control group. (D) Western blot analysis was performed to assess the protein expression levels of HLA-DPA1 and HLA-DPB1 in PBMCs. The results demonstrated that the protein levels of both genes were markedly downregulated in the asthma group compared with the healthy control group. GAPDH was used as a loading control. *P<0.05; **P<0.01; ***P<0.001; ****P<0.0001, Student’s t-test, one-way ANOVA, post hoc comparisons, Tukey’s test.

    Article Snippet: BEAS-2B (normal human bronchial epithelial) cells were purchased from ATCC and maintained in DMEM at 37 °C.

    Techniques: Biomarker Discovery, In Vitro, Real-time Polymerase Chain Reaction, Expressing, Control, Western Blot